The Safety, Efficacy and Therapeutic Potential of Histone Deacetylase Inhibitors with Special Reference to Panobinostat in Gastrointestinal Tumors: A Review of Preclinical and Clinical Studies

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|18|8|720-736

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.18, Iss.8, 2018-10, pp. : 720-736

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practice

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 210-216

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Pharmaceutical Potential of Histone Deacetylase Inhibitors

By  

Current Pharmaceutical Design, Vol. 13, Iss. 25, 2007-09 ,pp. : 2584-2620

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors in clinical development

By Rosato Roberto R   Grant Steven  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 1, 2004-01 ,pp. : 21-38

Informa Healthcare

Access to resources Recommend Favorite

A Review of Depsipeptide and Other Histone Deacetylase Inhibitors in Clinical Trials

By  

Current Pharmaceutical Design, Vol. 10, Iss. 19, 2004-07 ,pp. : 2289-2298

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Application of Histone Deacetylase Inhibitors for Stroke

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 2, 2011-06 ,pp. : 138-149

Bentham Science Publishers

Access to resources Recommend Favorite